F
Frederic Mercier
Researcher at Université de Montréal
Publications - 33
Citations - 464
Frederic Mercier is an academic researcher from Université de Montréal. The author has contributed to research in topics: Hyperthermic intraperitoneal chemotherapy & Cancer. The author has an hindex of 10, co-authored 33 publications receiving 253 citations. Previous affiliations of Frederic Mercier include University of Chicago & University of Lyon.
Papers
More filters
Journal ArticleDOI
Multicenter comprehensive methodological and technical analysis of 832 pressurized intraperitoneal aerosol chemotherapy (PIPAC) interventions performed in 349 patients for peritoneal carcinomatosis treatment: An international survey study.
Maciej Nowacki,Mohammad Alyami,Laurent Villeneuve,Frederic Mercier,Martin Hübner,Wouter Willaert,Wim Ceelen,Marc A. Reymond,Denis Pezet,Catherine Arvieux,Vladimir M. Khomyakov,Laura Lay,Sergio Gianni,Wojciech Zegarski,Naoual Bakrin,Olivier Glehen +15 more
TL;DR: Standardization of the procedure will facilitate future international multicenter prospective clinical trials and confirm that PIPAC procedures are homogeneously performed in established centers.
Journal ArticleDOI
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for unresectable peritoneal metastasis from gastric cancer.
Mohammad Alyami,Pierre-Emmanuel Bonnot,Frederic Mercier,Nathalie Laplace,Laurent Villeneuve,Guillaume Passot,Naoual Bakrin,Vahan Kepenekian,Olivier Glehen +8 more
TL;DR: PIPAC with low-dose cisplatin and doxorubicin is safe and feasible in association with systemic chemotherapy for gastric PM and justify further clinical studies in this indication.
Journal ArticleDOI
Unresectable peritoneal metastasis treated by pressurized intraperitoneal aerosol chemotherapy (PIPAC) leading to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Mohammad Alyami,Frederic Mercier,Matthieu Siebert,Pierre-Emmanuel Bonnot,Nathalie Laplace,Laurent Villeneuve,Guillaume Passot,Olivier Glehen,Naoual Bakrin,Vahan Kepenekian +9 more
TL;DR: Complete CRS and HIPEC can be achieved in strictly selected patient with unresectable PM at diagnosis after repeated PIPAC session with palliative intent, as described in this study.
Journal ArticleDOI
Normohormonal primary hyperparathyroidism is a distinct form of primary hyperparathyroidism.
Megan K. Applewhite,Michael G. White,Jennifer F. Tseng,Maryam K. Mohammed,Frederic Mercier,Edwin L. Kaplan,Peter Angelos,Tamara Vokes,Raymon H. Grogan +8 more
TL;DR: It is shown that normohormonal primary hyperparathyroidism is a distinct disease process from classic primaryHypercalcemia in presentation, imaging, and operative findings, and studies with long‐term follow‐up are needed to determine optimal operative management.
Journal ArticleDOI
Peritoneal Carcinomatosis of Rare Ovarian Origin Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Multi-Institutional Cohort from PSOGI and BIG-RENAPE.
Frederic Mercier,Naoual Bakrin,David L. Bartlett,Diane Goéré,François Quenet,Frédéric Dumont,Bruno Heyd,Karine Abboud,Christelle Marolho,Laurent Villeneuve,Olivier Glehen +10 more
TL;DR: CRS and HIPEC may increases long-term survival in selected patients with peritoneal metastasis from rare ovarian tumors especially in mucinous, granulosa, or teratoma histological subtypes.